StonvexLoading…
StonvexStonvexStonvexCore line items from REXR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $589.00K | $392.00K | $274.00K |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $91.19M | $212.03M | $277.45M | $187.53M |
EPS (Diluted) | $0.38 | $0.86 | $1.16 | $0.78 |
Total Assets | $12.40B | $12.61B | $12.85B | $13.08B |
Total Liabilities | $3.76B | $3.77B | $3.81B | $3.88B |
Cash & Equivalents | $51.71M | $165.78M | $248.96M | $431.12M |
Free Cash Flow OCF − CapEx | $78.13M | $208.66M | $178.84M | $118.36M |
Shares Outstanding | 226.29M | 231.58M | 232.81M | 236.69M |